Clinical Applications of Sentinel Lymph Node Biopsy in Ductal Carcinoma in situ of the Breast: A Dilemma
Open Access
- 1 January 2011
- journal article
- review article
- Published by Tohoku University Medical Press in The Tohoku Journal of Experimental Medicine
- Vol. 224 (1), 1-5
- https://doi.org/10.1620/tjem.224.1
Abstract
Breast cancer is the fifth most common cause of cancer deaths in the world, which often spreads first to the axillary lymph nodes (ALN) from the primary tumor. ALN helps clinician stage breast cancer. In addition, it is one of the key prognostic factors for patients with invasive breast cancer. The sentinel lymph node (SLN) is defined as the first regional lymph node to receive lymphatic fluid from a malignant tumor. As a result, it seems possible to assess the complete nodal status with sentinel lymph node biopsy (SLNB), which is attractive and reliable approach for identifying lymph node metastasis. Ductal carcinoma in situ (DCIS) is the most common type of non-invasive breast cancer. However, the role of SLNB in DCIS is controversial because DCIS does not cause invasion and metastasis theoretically. In this review, clinical applications of SLNB in DCIS will be discussed. The potential benefit of accurately upstaging patients with DCIS and the minimal invasiveness of SLNB justify use of SLNB in selected high-risk DCIS patients. At least DSIS with microinvasion, have DCIS of sufficient extent on mammography or MRI, or indicated invasive or microinvasive focus by final histological examination, are recommended for SLNB. Moreover, large randomized trials to evaluate the usefulness of SLNB in DCIS patients after long-term follow-up on local control and survival are required for further evaluation.Keywords
This publication has 29 references indexed in Scilit:
- The sentinel-node concept: a dramatic improvement in breast-cancer surgeryThe Lancet Oncology, 2010
- Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedureEuropean Journal of Surgical Oncology, 2010
- Sentinel lymph node biopsy in selected cases of ductal carcinoma in situClinical and Translational Oncology, 2010
- Malignant Precursor Cells Pre-Exist in Human Breast DCIS and Require Autophagy for SurvivalPLOS ONE, 2010
- Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?Journal of Clinical Pathology, 2009
- Microinvasive Carcinoma of the BreastPathology and Oncology Research, 2008
- Meta-analysis of sentinel node biopsy in ductal carcinomain situof the breastBritish Journal of Surgery, 2008
- Significance of Sentinel Lymph Node Micrometastases in Human Breast CancerJournal of the American College of Surgeons, 2008
- Sentinel Node Biopsy Is Not a Standard Procedure in Ductal Carcinoma In Situ of the BreastAnnals of Surgery, 2008
- Sentinel lymph node as a new marker for therapeutic planning in breast cancer patientsJournal of Surgical Oncology, 2004